Moiseenkova-Bell, Vera
- University of Pennsylvania · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,970
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,970
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Moiseenkova-Bell, Vera as a PI. Multi-PI records show the full award amount for context.
- 1S10OD030446-01A1S10Contact PIAcquisition of the Thermo Scientific Glacios transmission electron microscopeUniversity of Pennsylvania · Pharmacology (NIH department code)$2Maward amount
- 5R35GM144120-02R35Contact PIStructure and Function of TRPV channelsUniversity of Pennsylvania · Pharmacology (NIH department code)$888.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Moiseenkova-Bell, Vera as a PI.
FY2023 award administered by University of Pennsylvania (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardUniversity of Pennsylvania
- 2014$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2018$2M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #8824
- 2023$5M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #1970
- 2023Entered Top 10% NationallyRanked #1970